Search
for
Sort by
Research 91–120 of 1000+
- Spironolactone, a Classic Potassium-Sparing Diuretic, Reduces Survivin Expression and Chemosensitizes Cancer Cells to Non-DNA-Damaging Anticancer Drugs
- Role of sgk1 in cancer: a bibliometric analysis from 2013 to 2023—review article
- Increased copy number of the TERT and TERC telomerase subunit genes in cancer cells
- ONCO-NK-TRANSITION-GM1: The Bridge Cancer Therapy Manufacturable by Current Pharmaceutical Industry — 60-80% Cure Rate — $50 per Dose A Complete Transitional Drug from Full N‑K GM Series to Current Pharma Capability
- Premature aging and cancer development in transgenic mice lacking functional CYLD
- ONCO-NK-TRANSITION-GM1: The Bridge Cancer Therapy Manufacturable by Current Pharmaceutical Industry — 60-80% Cure Rate — $50 per Dose A Complete Transitional Drug from Full N‑K GM Series to Current Pharma Capability
- A NEW GENERATION OF MARKERS FOR CANCER DETECTION AND DRUG TRANSPORT
- Optimizing treatment management of trastuzumab deruxtecan in clinical practice of breast cancer
- Antiproliferative and antioxidant potential of Tridax procumbens extracts against various human cancer cell lines: An insight for medicines from weeds
- Ectopic Expression of a Truncated Isoform of Hair Keratin 81 in Breast Cancer Alters Biophysical Characteristics to Promote Metastatic Propensity
- REV7: a small but mighty regulator of genome maintenance and cancer development
- Bibliometric Analysis of Research Trends and Prospective Directions of Lung Microbiome
- Proliferation, but Not Apoptosis, Is Associated with Distinct β-Catenin Expression Patterns in Non-Small-Cell Lung Carcinomas
- Diagnostic Value of VDR in Bone Metastasis and Prognosis of Patients with Breast Cancer and Expression Correlation between Vitamin D Receptor and Hairless Protein
- Fourier Transform Infrared Attenuated Total Reflection Analysis of Human Hair: Comparison of Hair from Breast Cancer Patients with Hair from Healthy Subjects
- Design, Synthesis and Evaluation of N13-Substituted Evodiamine Derivatives against Human Cancer Cell Lines
- Management of Toxicities of Targeted Therapies
- Chrysin Increases the Therapeutic Efficacy of Docetaxel and Mitigates Docetaxel-Induced Edema
- Coexistence of angiolymphoid hyperplasia with eosinophilia and pulmonary neoplasia
- Gefitinib
- The protective role of the immunomodulator AS101 against chemotherapy-induced alopecia studies on human and animal models
- Angelica Sinensis and Chinese Arborvitae: A Review on its Phytochemical & Pharmacological Importance
- An Opportunity Missed: Managing an Aggressive Adrenal Cortical Carcinoma
- Dermatological side effects of epidermal growth factor receptor inhibitors: ′Pride′ complex
- Erosive Pustular Dermatosis of the Scalp-Like Eruption due to Gefitinib: Case Report and Review of the Literature of Alopecia Associated with EGFR Inhibitors
- Formulation of Chitosan-Coated Brigatinib Nanospanlastics: Optimization, Characterization, Stability Assessment and In-Vitro Cytotoxicity Activity against H-1975 Cell Lines
- “PRIDE” Complex
- A prospective observational study on drug safety monitoring and Pharmacoeconomics in patients with locally advanced unresectable NSCLC in a tertiary care hospital
- Erlotinib-related Severe Hair Loss with Severe Exanthematous Drug Eruption: A Case Report
- Ginseng phytochemicals as therapeutics in oncology: Recent perspectives